Trade Ionis Pharmaceuticals, Inc. - IONS CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.34 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023512% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.00129% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 32.58 |
| Open | 32.19 |
| 1-Year Change | -27.37% |
| Day's Range | 31.96 - 32.58 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Feb 21, 2025 | 32.15 | -0.30 | -0.92% | 32.45 | 32.69 | 31.87 |
| Feb 20, 2025 | 32.58 | 1.14 | 3.63% | 31.44 | 32.96 | 30.57 |
| Feb 19, 2025 | 31.61 | -2.54 | -7.44% | 34.15 | 34.49 | 30.85 |
| Feb 18, 2025 | 31.77 | 0.67 | 2.15% | 31.10 | 32.11 | 30.91 |
| Feb 14, 2025 | 30.89 | 0.72 | 2.39% | 30.17 | 31.43 | 30.17 |
| Feb 13, 2025 | 30.19 | -0.34 | -1.11% | 30.53 | 30.83 | 30.12 |
| Feb 12, 2025 | 30.70 | -0.37 | -1.19% | 31.07 | 31.47 | 30.24 |
| Feb 11, 2025 | 31.53 | 0.59 | 1.91% | 30.94 | 31.53 | 30.68 |
| Feb 10, 2025 | 31.41 | 0.46 | 1.49% | 30.95 | 31.54 | 30.95 |
| Feb 7, 2025 | 31.35 | -1.01 | -3.12% | 32.36 | 32.63 | 31.27 |
| Feb 6, 2025 | 32.53 | -0.53 | -1.60% | 33.06 | 33.21 | 32.21 |
| Feb 5, 2025 | 33.12 | 1.79 | 5.71% | 31.33 | 33.22 | 31.33 |
| Feb 4, 2025 | 31.56 | -0.29 | -0.91% | 31.85 | 32.25 | 31.25 |
| Feb 3, 2025 | 32.04 | 1.08 | 3.49% | 30.96 | 32.36 | 30.96 |
| Jan 31, 2025 | 31.73 | -0.54 | -1.67% | 32.27 | 33.67 | 31.68 |
| Jan 30, 2025 | 33.08 | 0.13 | 0.39% | 32.95 | 33.26 | 31.69 |
| Jan 29, 2025 | 32.75 | -1.17 | -3.45% | 33.92 | 34.08 | 32.58 |
| Jan 28, 2025 | 34.04 | 0.61 | 1.82% | 33.43 | 34.57 | 33.43 |
| Jan 27, 2025 | 33.99 | -0.16 | -0.47% | 34.15 | 35.18 | 33.44 |
| Jan 24, 2025 | 34.61 | 0.46 | 1.35% | 34.15 | 34.78 | 33.51 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Ionis Pharmaceuticals Company profile
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; and Kynamro an oligonucleotide inhibitor for use in patients with homozygous familial hypercholesterolemia to reduce low density lipoprotein-cholesterol, apolipoprotein B, total cholesterol, and non-high density lipoprotein. It is also developing inotersen, an antisense drug Ionis to treat patients with hereditary transthyretin amyloidosis; and volanesorsen, an antisense drug for the treatment of familial chylomicronemia syndrome and familial partial lipodystrophy. In addition, the company is developing drugs for various indications, such as cardiometabolic diseases caused by lipid disorders; cardiovascular disease, clotting disorders, and Alzheimer's and Parkinson's diseases; and acromegaly, amyotrophic lateral sclerosis, beta-thalassemia, and Huntington's disease. Ionis Pharmaceuticals, Inc. has a collaboration agreement with AstraZeneca to discover and develop antisense therapies for treating cardiovascular and metabolic diseases, and cancer; and Biogen Inc. to develop and commercialize therapies for neurological disorders, SMA, and neurodegenerative diseases. The company was formerly known as Isis Pharmaceuticals, Inc. and changed its name to Ionis Pharmaceuticals, Inc. in December 2015. Ionis Pharmaceuticals, Inc. was founded in 1989 and is headquartered in Carlsbad, California.| Industry: | Biotechnology & Medical Research (NEC) |
2855 Gazelle Court
CARLSBAD
CALIFORNIA 92010
US
News
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025
Ripple XRP price prediction: Third-party price target
Discover the ripple (XRP) price predictions for 2025 and beyond, with analyst price targets and CFDs trading strategies on Capital.com
15:29, 6 February 2025
Apple (AAPL) stock price forecast: third-party price target
We looked at the forecasts for Apple stock in 10 years to see where the price would likely be at that point and the challenges the company could face. Read more.
11:22, 6 February 2025
FARTCOIN price prediction: Third-party price target
Read our FARTCOIN price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:18, 29 January 2025
MELANIA coin ($MELANIA) price prediction: Third party price target
Read our MELANIA crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts.
11:33, 22 January 2025
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:52, 22 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025People also watch
Still looking for a broker you can trust?
Join the 690,000+ traders worldwide that chose to trade with Capital.com